# Baclofen in the Treatment of Alcohol Dependence With or Without Alcoholic Liver Disease

> **NCT01711125** · PHASE3 · COMPLETED · sponsor: **South West Sydney Local Health District** · enrollment: 104 (actual)

## Conditions studied

- Alcoholic Liver Disease
- Alcohol Dependence

## Interventions

- **DRUG:** Baclofen 30mg/day
- **DRUG:** Baclofen 75mg/day
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01711125
- **Lead sponsor:** South West Sydney Local Health District
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2017-08-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01711125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01711125, "Baclofen in the Treatment of Alcohol Dependence With or Without Alcoholic Liver Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01711125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*